Agilus 120 mg

Agilus 120 mg is a medicine authorised by Swissmedic under authorisation number 69083. The authorisation holder is Norgine AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 27 June 2024 and the authorisation is limited until 26 June 2029. ATC code M03CA01 places the medicine in the group Muscle relaxants.

  • Dispensing category B
  • Authorisation number 69083
  • ATC M03CA01
  • Synthetic medicines
Authorisation data
Authorisation number69083
NameAgilus 120 mg
Full nameAgilus 120 mg, Pulver zur Herstellung einer Injektionslösung
Authorisation holderNorgine AG
Medicinal product codeSynthetic medicines
Dispensing categoryB · Prescription only
ATC codeM03CA01
First authorisation27 June 2024
Authorisation validity26 June 2029
Strengths
No.NameDispensing categoryAuthorisation date
1Agilus 120 mg, Pulver zur Herstellung einer InjektionslösungB27 June 2024

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
16Durchstechflasche(n)M03CA0101.12.0.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Agilus 120 mg authorised in Switzerland?

Yes. Agilus 120 mg is authorised by Swissmedic under authorisation number 69083, data as of 01 September 2026. The authorisation is limited until 26 June 2029.

Which dispensing category does Agilus 120 mg have?

Agilus 120 mg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Agilus 120 mg?

The authorisation holder is Norgine AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com